The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/Ib study of lenvatinib and cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
 
Lara Dunn
Consulting or Advisory Role - CUE Biopharma; CUE Biopharma; Regeneron
Research Funding - Eisai; Pfizer; Regeneron
 
Alan Loh Ho
Consulting or Advisory Role - AstraZeneca; Ayala Pharmaceuticals; Bristol-Myers Squibb; CureVac; CureVac; Eisai; Genzyme; Merck; Novartis; Regeneron; Sanofi; Sun Pharma; TRM Oncology
Speakers' Bureau - Medscape; Novartis; Omniprex America
Research Funding - Allos Therapeutics; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Ayala Pharmaceuticals; Ayala Pharmaceuticals; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Elevar Therapeutics; Genentech/Roche; Kolltan Pharmaceuticals; Kura Oncology; Lilly; Merck; Novartis; Novartis; Novartis; Pfizer
Travel, Accommodations, Expenses - Ayala Pharmaceuticals; Ignyta; Janssen Oncology; Klus Pharma; Kura Oncology; Kura Oncology; Kura Oncology; Merck
 
Juliana Eng
No Relationships to Disclose
 
Loren S. Michel
Research Funding - Exelixis (Inst)
Travel, Accommodations, Expenses - Immunomedics
 
James Vincent Fetten
No Relationships to Disclose
 
Elizabeth Warner
No Relationships to Disclose
 
Anuja Kriplani
No Relationships to Disclose
 
Wanqing Iris Zhi
No Relationships to Disclose
 
Kenneth K. Ng
No Relationships to Disclose
 
Sofia Haque
Honoraria - Advance Medical
Consulting or Advisory Role - Advance Medical
 
David G. Pfister
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Incyte
Research Funding - AstraZeneca; Atara Biotherapeutics; Bayer (Inst); Boehringer Ingelheim; Eisai (Inst); Exelixis; Genentech/Roche (Inst); Lilly (Inst); MedImmune; Merck; Novartis; Regeneron
 
Eric Jeffrey Sherman
Consulting or Advisory Role - Cota Healthcare; Eisai; Goldilocks; Lilly; Regeneron; UpToDate
Research Funding - Plexxikon